Cargando…
Nanomedicine approaches for treatment of hematologic and oncologic malignancies
Cancer is a leading cause of death worldwide. Nowadays, the therapies are inadequate and spur demand for improved technologies. Rapid growth in nanotechnology and novel nanomedicine products represents an opportunity to achieve sophisticated targeting strategies and multi-functionality. Nanomedicine...
Autores principales: | Nteli, Polyxeni, Bajwa, Danae Efremia, Politakis, Dimitrios, Michalopoulos, Charalampos, Kefala-Narin, Anastasia, Efstathopoulos, Efstathios P, Gazouli, Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9346428/ https://www.ncbi.nlm.nih.gov/pubmed/36157164 http://dx.doi.org/10.5306/wjco.v13.i7.553 |
Ejemplares similares
-
Nanomedicine for Immunotherapy Targeting Hematological Malignancies: Current Approaches and Perspective
por: Allegra, Alessandro, et al.
Publicado: (2021) -
Development and application of nanomaterials, nanotechnology and nanomedicine for treating hematological malignancies
por: Li, Jinxin, et al.
Publicado: (2023) -
Surfactant and Block Copolymer Nanostructures: From Design and Development to Nanomedicine Preclinical Studies
por: Kontogiannis, Orestis, et al.
Publicado: (2023) -
Editorial: Advanced Theranostic Nanomedicine in Oncology
por: Tapeinos, Christos, et al.
Publicado: (2020) -
The Impact of an Embedded Oncology Pharmacist in an Outpatient Oncology Center in the Treatment of Hematologic Malignancies
por: Mae Trinidad, Denisse, et al.
Publicado: (2022)